Search results for: 'data analytics market'

This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...

As the number of aging, technologically obsolete imaging systems at medical facilities increases the need to shift to new imaging equipment with advanced technology, hospitals and imaging centers especially in developing economies seek MES models that provide a viable long-term equipment procurement strategy. MES offers technical infrastructure sup...

This study analyzes several patient monitoring devices, such as blood pressure monitors, fetal and maternal monitors, multiparameter monitors, pulse oximeters, and spirometers. It addresses critical questions such as industry size, growth rates, growth opportunities, strategic imperatives, technology impact, and new business models. Regional covera...

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical device industries. What started in the late 1990s as a...

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, comp...

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...

The North American and European multi-vendor services (MVS) market is expected to witness significant changes over the next couple of years, driven by the increasing adoption of technology by both MVS providers and healthcare facilities, the shift from inpatient to outpatient settings for surgical procedures, and the rising use of medical equipment...

Frost & Sullivan defines digital health as data application for healthcare delivery using computational and telecommunication technologies to support business process workflow, clinical workflow, and patient data management. Digital health aims to achieve better patient outcomes while improving efficiency and containing costs through provider and p...